ChemoCentryx
CCXI
#3623
Rank
A$5.58 B
Marketcap
A$77.72
Share price
0.00%
Change (1 day)
23.73%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): A-$2.61

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is A-$2.83. In 2021 the company made an earnings per share (EPS) of A-$2.83 a decrease over its 2020 EPS that were of A-$1.21.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)A-$2.61-7.46%
2021A-$2.83133.33%
2020A-$1.21-16.49%
2019A-$1.4527.63%
2018A-$1.14-305.41%
2017A$0.55-142.53%
2016A-$1.30-19.44%
2015A-$1.61-0%
2014A-$1.6113.68%
2013A-$1.42-16.67%
2012A-$1.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
A$16.43-681.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.02-171.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$5.38-290.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
A$4.44-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$15.61-652.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$19.48-789.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.57-191.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$0.94-133.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
A$11.35-501.79%๐Ÿ‡บ๐Ÿ‡ธ USA